Dr. David Cowan is Professor Emeritus in the Department of Environmental, Analytical, and Forensic Science at King's College London. He joins us in this interview to talk more about advances in methods for detecting and measuring peptides and proteins in anti-doping, including work on insulin, IGF-1, and P-III-NP. He also shares updates on a PCC-funded Micro-Grant project and some of the other excellent anti-doping research projects at King's College London.

Professor Andrea Petroczi is Professor of Public Health at Kingston University London, and she is Chair of the WADA Working Group on Doping Prevalence. Andrea has various areas of expertise in anti-doping, but in this episode we focus our conversation on doping prevalence. She discusses exciting new research in the field, challenges, and opportunities for the future.

Liesl Janssens is a PhD Student at the laboratory of Toxicology at Ghent University. She joins us again in this episode to give us an update on her research focused on developing new detection methods for Hypoxia-inducible factor (HIF) stabilizers. She also discusses recent work that she and her colleagues have been doing to characterize and detect cannabinoids, opioids, and psychedelics using similar activity-based assays.

Dr. Fredrik Lauritzen is the Science Director at Anti-Doping Norway. In this episode, he shares more about Anti-Doping Norway, use of intelligence-based approaches in anti-doping, and his recent research investigating the effectiveness of using intelligence in the doping control test planning process. You can contact Fredrik by email at fredrik.lauritzen[at]antidoping.no with any questions.

Dr. Raphaël Faiss is Research Manager at the Center for Research & Expertise in Anti-Doping sciences (REDs) and Senior Lecturer in Exercise Physiology at the University of Lausanne. He is also a former elite cyclist. In this episode, Raphaël shares more about the REDs, anti-doping research, and some of his current research projects, including work investigating potential confounding factors in the Athlete Biological Passport. He also discusses his collaboration on a PCC-funded research project investigating the potential use of performance monitoring to augment anti-doping efforts.

Renee Tomb is Director of Policy Administration at PGA TOUR. In this episode, Renee discusses her work, PGA TOUR's Anti-Doping Program, and why the PGA TOUR's clean sport efforts are so critical.

Jane Rumble is Chief Executive at UK Anti-Doping (UKAD). In our conversation, we discuss Jane's career, UKAD and its history, their efforts to ensure clean sport in the UK, and how the organization has changed and incorporated new innovations over the years.

Dr. Andrew Jones is the CEO and Co-Founder of Activated Research Company, a company dedicated to creating new products to make chemical analysis easy and accessible. In our conversation, we talk more about Andrew's career, the innovative products he is developing at Activated Research Company, and how their products can be used to advance anti-doping.

Dr. Chris Chouinard is an Assistant Professor in the Department of Chemistry at Clemson University. In this episode, we discuss Chris's career, his PCC-funded research investigating the development and potential applications of ion mobility-mass spectrometry for anti-doping, and how his work may impact anti-doping and other fields.

Tony Cunningham is a Senior Manager in the Education Department with responsibility for Social Science Research and Policy at the World Anti-Doping Agency (WADA). In our interview, we talk more about Tony's career, education initiatives at WADA, the International Standard for Education and the impacts it is having on anti-doping education, as well as support for social science research at WADA.